221 related articles for article (PubMed ID: 27841121)
1. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.
Simo R; Robinson M; Lei M; Sibtain A; Hickey S
J Laryngol Otol; 2016 May; 130(S2):S97-S103. PubMed ID: 27841121
[TBL] [Abstract][Full Text] [Related]
2. Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.
Pracy P; Loughran S; Good J; Parmar S; Goranova R
J Laryngol Otol; 2016 May; 130(S2):S104-S110. PubMed ID: 27841124
[TBL] [Abstract][Full Text] [Related]
3. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
4. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.
Jones TM; De M; Foran B; Harrington K; Mortimore S
J Laryngol Otol; 2016 May; 130(S2):S75-S82. PubMed ID: 27841116
[TBL] [Abstract][Full Text] [Related]
5. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Paleri V; Urbano TG; Mehanna H; Repanos C; Lancaster J; Roques T; Patel M; Sen M
J Laryngol Otol; 2016 May; 130(S2):S161-S169. PubMed ID: 27841133
[TBL] [Abstract][Full Text] [Related]
6. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Evans M; Beasley M; Chatterjee S; Dilkes M; Homer J; O'Hara J; Robinson M; Shaw R; Sloan P
J Laryngol Otol; 2016 May; 130(S2):S90-S96. PubMed ID: 27841123
[TBL] [Abstract][Full Text] [Related]
7. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
8. Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines.
Mackenzie K; Watson M; Jankowska P; Bhide S; Simo R
J Laryngol Otol; 2016 May; 130(S2):S170-S175. PubMed ID: 27841129
[TBL] [Abstract][Full Text] [Related]
9. Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Lewis-Jones H; Colley S; Gibson D
J Laryngol Otol; 2016 May; 130(S2):S28-S31. PubMed ID: 27841111
[TBL] [Abstract][Full Text] [Related]
10. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines.
Ahmed OA; Kelly C
J Laryngol Otol; 2016 May; 130(S2):S133-S141. PubMed ID: 27841141
[TBL] [Abstract][Full Text] [Related]
11. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
12. Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Teo PT; Tan NC; Khoo JB
Clin Radiol; 2013 Nov; 68(11):e629-38. PubMed ID: 23937825
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease.
Manavis J; Sivridis L; Koukourakis MI
Clin Imaging; 2005; 29(2):128-33. PubMed ID: 15752969
[TBL] [Abstract][Full Text] [Related]
14. Management of lateral skull base cancer: United Kingdom National Multidisciplinary Guidelines.
Homer JJ; Lesser T; Moffat D; Slevin N; Price R; Blackburn T
J Laryngol Otol; 2016 May; 130(S2):S119-S124. PubMed ID: 27841125
[TBL] [Abstract][Full Text] [Related]
15. Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Simo R; Homer J; Clarke P; Mackenzie K; Paleri V; Pracy P; Roland N
J Laryngol Otol; 2016 May; 130(S2):S208-S211. PubMed ID: 27841136
[TBL] [Abstract][Full Text] [Related]
16. The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer.
Fujii M; Kanzaki J
Auris Nasus Larynx; 1994; 21(1):32-7. PubMed ID: 7980192
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of recurrent nasopharyngeal carcinoma.
Hao SP; Tsang NM
Chang Gung Med J; 2010; 33(4):361-9. PubMed ID: 20804665
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
19. [Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
Lin Q; Yang RS; Sun L; Li YM; Wang LC; Dai MM; Luo ZM; Zhao L; Wu H
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):356-9. PubMed ID: 22883456
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors.
Hao SP; Tsang NM; Chang KP; Hsu YS; Chen CK; Fang KH
Acta Otolaryngol; 2008 Apr; 128(4):473-81. PubMed ID: 18368585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
